Fig. 1From: Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD studyMRI scan (coronal T2-weighted image) of a patient with severe PLD and ongoing liver growth despite somatostatin analogue use, that would be eligible for the AGAINST-PLD studyBack to article page